Overview
Leading the Way: Improving Breast Cancer Disparities for Minority Patients in Chicago Race, Ethnicity, and Breast Cancer: Screening and Diagnosis
Expert Perspectives
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
This activity was included in a series of workshops as part of a quality improvement program “Leading the Way: Improving Breast Cancer Disparities for Minority Patients in Chicago.” Led by Olufunmilayo Olopade, MD, FACP, this initiative is studying the effectiveness of targeted interventions in improving breast cancer care for African American women treated in Cook County.
In this workshop, Dr. Nan Chen from the University of Chicago Medicine discusses screening and mammography rates among racial/ethnic groups. Dr. Chen also touches on the impact of the COVID-19 pandemic, factors that influence disparities such as fears and misperceptions, the underutilization of genetic counseling and testing, and the importance of patient communication and navigation. Learn how you can address disparities in your own patient care.
This activity is intended for clinical (oncologists, surgical oncologists, radiologists, oncology nurses, OB-GYNs, internal medicine physicians, NPs, PAs and technologists) and administrative teams (case managers, patient navigators, assistive personnel) who care for breast cancer patients.
Compared to white women, Black women are less likely to be diagnosed with breast cancer. However, Black women are more likely to be diagnosed at a later stage, have more aggressive subtypes, and experience delays in receiving a diagnosis. Most devastatingly, they are more likely to die from their cancer.
Upon completion of this activity, participants will be able to:
• Describe racial and ethnic differences in screening mammography and diagnosis of breast cancer
• Recall the social determinants of health that may contribute to disparities in the diagnosis of breast cancer
• Discuss the principles of patient navigation and support that can be implemented to address disparities in the screening and diagnosis of breast cancer
• Describe racial and ethnic differences in screening mammography and diagnosis of breast cancer
• Recall the social determinants of health that may contribute to disparities in the diagnosis of breast cancer
• Discuss the principles of patient navigation and support that can be implemented to address disparities in the screening and diagnosis of breast cancer
• Racial Disparities
• Screening and Diagnosis
• Social Determinants of Health
• Patient Communication and Navigation
• Screening and Diagnosis
• Social Determinants of Health
• Patient Communication and Navigation
Sponsored by the University of Chicago Comprehensive Cancer Center, the University of Chicago Center for Continuing Medical Education, University of Illinois Chicago Cancer Center and their Chicago Cancer Screening and Testing Access Coalition (CCSTAC), and the Academy for Continued Healthcare Learning (ACHL).
Supported by educational grants from Daiichi Sankyo and AstraZeneca.
1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
Chair
Olufunmilayo I. Olopade, MD, FASCO
Walter L. Palmer Distinguished Service Professor of Medicine
Professor of Human Genetics
Professor of Comprehensive Cancer Research Center
Director, Center for Clinical Cancer Genetics and Global Health
University of Chicago
Chicago, IL
Faculty
Nan Chen, MD
Assistant Professor of Medicine
The University of Chicago
Chicago, IL
The University of Chicago Pritzker School of Medicine requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been mitigated prior to this activity.
The following financial relationships have been provided:
Olufunmilayo I. Olopade, MD, FASCO (Chair) is the co-founder of CancerIQ, on the Scientific Advisory Board for Tempus, Inc., and on the board of directors for 54gene and Healthwell Corporation.
Nan Chen, MD, (Faculty) has no financial relationships to disclose
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 15 minutes to complete. To receive credit, participants are required to view the online activity and complete the evaluation. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professional Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
